Vitreoretinal lymphoma presenting as amaurosis fugax. [PDF]
Purpose: To describe a case of vitreoretinal lymphoma with unilateral vascular involvement. Observations: A 80-year-old male with recurrent amaurosis fugax (AF) in the left eye was seen in the ophthalmological department.
Arnold-Vangsted A +4 more
europepmc +3 more sources
Purpose: To report two cases of vitreoretinal lymphoma that developed following primary testicular lymphoma and review the literature. Observations: Two men, one age 66 and the other age 77, both with a history of diffuse large B-cell testicular lymphoma,
Joseph Alsberge, Robert N Johnson
exaly +3 more sources
Vitreoretinal lymphoma revealing Richter transformation. [PDF]
Purpose: To report a rare case of Richter syndrome transformation presenting as diffuse large B-cell vitreoretinal lymphoma (DLBCL) in a patient with chronic lymphocytic leukemia (CLL).
Prabha D, Raval V, Mishra D.
europepmc +2 more sources
Molecular diagnosis of vitreoretinal lymphoma. [PDF]
Vitreoretinal lymphoma (VRL) is a rare ocular malignancy that involves the retina, the retinal pigment epithelium, and the vitreous. It is a subtype of primary central nervous system lymphoma (CNSL).
Kwak JJ, Lee CS.
europepmc +2 more sources
Rapidly progressive primary vitreoretinal lymphoma with optic disc involvement and retinal detachment. [PDF]
Purpose: This report presents a diagnostically challenging and aggressive case of primary vitreoretinal lymphoma, demonstrating the potential for recovery following early diagnostic vitrectomy and prompt intravitreal methotrexate. Observations: A 42-year-
Akada M +5 more
europepmc +2 more sources
Exploration of the Optimal Treatment Modality for Vitreoretinal Lymphoma: A PRISMA Compliant Meta-Analysis and Systematic Review. [PDF]
ABSTRACT Background Vitreoretinal lymphoma (VRL) is regarded as a subtype of primary central nervous system lymphoma (PCNSL). Hence, extending progression‐free survival (PFS) is crucial for enhancing the prognosis of VRL patients. Nevertheless, a lack of standard treatment options currently exists for VRL.
Gao J, Lv LW, Yang J, Wang HN, Wang L.
europepmc +2 more sources
Orelabrutinib and rituximab regimen combined with intravitreal methotrexate for treatment of primary vitreoretinal lymphoma: a case report and literature review. [PDF]
Primary vitreoretinal lymphoma (PVRL) is a rare intraocular malignancy for which the optimal therapeutic strategy remains controversial, largely due to the disease’s rarity and considerable heterogeneity in treatment approaches across medical centers ...
Li Y, Qiao R, Zhang X, Li Y.
europepmc +2 more sources
Molecular analysis of bilateral T-cell vitreoretinal lymphoma. [PDF]
A 63-year-old female who presented with bilateral panuveitis suspicious for a neoplastic etiology, underwent diagnostic pars plana vitrectomy of her right eye. Cytology was negative and flow cytometry did not reveal evidence of B-cell lymphoma.
Soifer M +8 more
europepmc +2 more sources
An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators. [PDF]
Primary vitreoretinal lymphoma is an incredibly rare non‐Hodgkin lymphoma with no clear international consensus guidelines for diagnosis and management. This study highlights the significant real‐world heterogeneity in diagnostic and management approaches of this rare condition. In particular, the incorporation of systemic therapy to initial management
Tang C +17 more
europepmc +2 more sources
Clinical guidelines for the diagnosis and treatment of vitreoretinal lymphoma in Chinese patients (2024). [PDF]
Vitreoretinal lymphoma (VRL) is often a diffuse large B-cell lymphoma in nature, and patients may have or eventually develop central nervous system lymphoma, which frequently leads to a poor prognosis.
Zhang X +8 more
europepmc +2 more sources

